Transient Ischemic Attack (TIA), Emergency Medicine

Doctor123.org

Transient Ischemic Attack (TIA), Emergency Medicine

Basics

Description

All children with TIA should be admitted for close neurologic observation, with strong consideration of ICU level care

  • TIA " “ an episode of reversible neurologic deficit caused by a temporary decrease in blood flow to an area of the central nervous system (CNS)
  • Classically described as symptoms lasting <24 hr, but most TIA symptoms resolve in <1 hr
  • A warning for stroke, as 12 " “30% of strokes will be preceded by TIA

Etiology

  • Transient decrease in perfusion to an area of the CNS, which can be caused by:Thrombosis in medium to large arteries with atherosclerosis (25%)Intracranial small vessel disease (25%)Embolic cause from the heart (20%)Miscellaneous, including arterial dissection, vasculitis, and hypercoagulable states (5%)No clear predisposing vascular cause found (25%)
  • Thrombosis in medium to large arteries with atherosclerosis (25%)
  • Intracranial small vessel disease (25%)
  • Embolic cause from the heart (20%)
  • Miscellaneous, including arterial dissection, vasculitis, and hypercoagulable states (5%)
  • No clear predisposing vascular cause found (25%)

Diagnosis

Signs and Symptoms

  • Symptoms are determined by the vascular territories which are affected
  • Large vessel TIA syndromes:Anterior cerebral artery (ACA) " “ unilateral motor/sensory loss to leg > arm, disinhibitionMiddle cerebral artery (MCA) " “ unilateral motor/sensory loss to face/arm > leg, aphasia if dominant hemisphere, neglect if nondominant hemisphere, homonymous hemianopsiaPosterior cerebral artery (PCA) " “ homonymous hemianopsia, may have alexia, prosopagnosia (cant recognize faces)Anterior inferior cerebellar artery (AICA) " “ unilateral deafness, vertigo, tinnitus, vomiting, ipsilateral facial weakness and limb ataxia, contralateral decrease in pain and temperature sensationPosterior inferior cerebellar artery (PICA) " “ unilateral palatal weakness, unilateral limb ataxia, unilateral Horner's syndrome, decreased pain/temperature sensation on contralateral body:Wallenberg syndromeVertebrobasilar artery " “ ataxia, oculomotor palsies, facial paresis, loss of consciousness, quadriplegiaCarotid artery " “ unilateral motor/sensory loss to face/leg/arm, aphasia if dominant hemisphere, neglect if nondominant hemisphere, homonymous hemianopsia
  • Small vessel TIA syndromes:Amaurosis fugax " “ transient monocular blindness from occlusion of ophthalmic branch of internal carotidLacunar infarcts " “ occlusion of a deep penetrating artery of the brain. Usually produce pure motor or pure sensory deficitsInternal capsule " “ hemiparesis or dysarthria with clumsy handCorona radiata " “ hemiparesisPons " “ dysarthria with clumsy handThalamus " “ sensory loss to 1 side of the body
  • Anterior cerebral artery (ACA) " “ unilateral motor/sensory loss to leg > arm, disinhibition
  • Middle cerebral artery (MCA) " “ unilateral motor/sensory loss to face/arm > leg, aphasia if dominant hemisphere, neglect if nondominant hemisphere, homonymous hemianopsia
  • Posterior cerebral artery (PCA) " “ homonymous hemianopsia, may have alexia, prosopagnosia (cant recognize faces)
  • Anterior inferior cerebellar artery (AICA) " “ unilateral deafness, vertigo, tinnitus, vomiting, ipsilateral facial weakness and limb ataxia, contralateral decrease in pain and temperature sensation
  • Posterior inferior cerebellar artery (PICA) " “ unilateral palatal weakness, unilateral limb ataxia, unilateral Horner's syndrome, decreased pain/temperature sensation on contralateral body:Wallenberg syndrome
  • Vertebrobasilar artery " “ ataxia, oculomotor palsies, facial paresis, loss of consciousness, quadriplegia
  • Carotid artery " “ unilateral motor/sensory loss to face/leg/arm, aphasia if dominant hemisphere, neglect if nondominant hemisphere, homonymous hemianopsia
  • Wallenberg syndrome
  • Amaurosis fugax " “ transient monocular blindness from occlusion of ophthalmic branch of internal carotid
  • Lacunar infarcts " “ occlusion of a deep penetrating artery of the brain. Usually produce pure motor or pure sensory deficitsInternal capsule " “ hemiparesis or dysarthria with clumsy handCorona radiata " “ hemiparesisPons " “ dysarthria with clumsy handThalamus " “ sensory loss to 1 side of the body
  • Internal capsule " “ hemiparesis or dysarthria with clumsy hand
  • Corona radiata " “ hemiparesis
  • Pons " “ dysarthria with clumsy hand
  • Thalamus " “ sensory loss to 1 side of the body
  • Historical features suggestive of TIA:Sudden onsetShort duration (as >60% of events last <1 hr)Negative symptoms " “ CNS is underperfused and therefore, not functioning, so TIA syndromes generally produce loss of neurologic function " “ i.e., weakness or aphasiaSymptoms are focal, related to specific vascular territory
  • Historical features not suggestive of TIA:Gradual onsetPositive symptoms " “ increased neurologic function in a particular area, such as convulsion, tingling, or twitching, suggests increased CNS activity as with migraine or seizure
  • Sudden onset
  • Short duration (as >60% of events last <1 hr)
  • Negative symptoms " “ CNS is underperfused and therefore, not functioning, so TIA syndromes generally produce loss of neurologic function " “ i.e., weakness or aphasia
  • Symptoms are focal, related to specific vascular territory
  • Gradual onset
  • Positive symptoms " “ increased neurologic function in a particular area, such as convulsion, tingling, or twitching, suggests increased CNS activity as with migraine or seizure
  • Detailed neurologic exam: Strength, sensation, coordination, gait, naming/speech, and visual fields
  • Persistent neurologic deficits suggest acute stroke rather than TIA
  • The National Institute of Health Stroke Scale (NIHSS) is a reliable and easily repeatable neurologic exam (http://www.ninds.nih.gov/doctors/NIH_Stroke_Scale.pdf)

Essential Workup

  • Rapid history and physical exam including detailed neurologic exam
  • Fingerstick glucose " “ hypoglycemia can produce focal neurologic deficits
  • Noncontrast CT head " “ rule out hemorrhage
  • If patients present with persistent deficits, obtain STAT neurologic consultation with concern for acute stroke rather than TIA

Diagnosis Tests & Interpretation

  • Glucose
  • Chemistry panel " “ check Na, renal function
  • CBC " “ exclude anemia, polycytosis
  • Troponin " “ rule out concomitant ACS or demand ischemia
  • Hemoglobin A1C and fasting lipid panel for patients being admitted/observed
  • CT:Upon arrival to ED, STAT noncontrast head CT to rule out CNS hemorrhage
  • MRI:Up to 50% of patients that clinically have a TIA will have evidence of infarction on MRI:Goal is to have MRI in <24 hrDiffusion-weighted imaging (DWI) is the most sensitive protocol for detection of tissue infarction
  • Vascular imaging:Either with initial imaging or inpatient workup, perform vascular imaging of the head and neck:Almost 50% of patients with TIA have stenosis or occlusion of large arteriesCarotid duplex ultrasound can be used to detect internal carotid stenosisCT angiography:Can be performed at the time of initial noncontrast head CTCan be used to detect stenosis in intracranial and extracranial vesselsRequires contrastMR angiography:Can be used to detect stenosis in intracranial and extracranial vesselsTime of flight (TOF) sequences can provide angiographic images without contrast
  • Upon arrival to ED, STAT noncontrast head CT to rule out CNS hemorrhage
  • Up to 50% of patients that clinically have a TIA will have evidence of infarction on MRI:Goal is to have MRI in <24 hr
  • Diffusion-weighted imaging (DWI) is the most sensitive protocol for detection of tissue infarction
  • Goal is to have MRI in <24 hr
  • Either with initial imaging or inpatient workup, perform vascular imaging of the head and neck:Almost 50% of patients with TIA have stenosis or occlusion of large arteries
  • Carotid duplex ultrasound can be used to detect internal carotid stenosis
  • CT angiography:Can be performed at the time of initial noncontrast head CTCan be used to detect stenosis in intracranial and extracranial vesselsRequires contrast
  • MR angiography:Can be used to detect stenosis in intracranial and extracranial vesselsTime of flight (TOF) sequences can provide angiographic images without contrast
  • Almost 50% of patients with TIA have stenosis or occlusion of large arteries
  • Can be performed at the time of initial noncontrast head CT
  • Can be used to detect stenosis in intracranial and extracranial vessels
  • Requires contrast
  • Can be used to detect stenosis in intracranial and extracranial vessels
  • Time of flight (TOF) sequences can provide angiographic images without contrast
  • ECG " “ evaluate for thrombogenic rhythms such as atrial fibrillation
  • Echocardiography in patients with no other cause for TIA " “ exclude existing thrombus and abnormal wall motion or aneurysms that cause thrombus

Differential Diagnosis

  • Hypoglycemia
  • Seizure
  • Paralysis after seizure (Todds paralysis)
  • Atypical migraine
  • Psychiatric disease
  • Stroke
  • CNS tumors or metastases
  • Subdural hemorrhage
  • Subarachnoid hemorrhage
  • Multiple sclerosis
  • Intracerebral hemorrhage
  • Air embolism
  • Vasculitis
  • Arterial dissection
  • Congenital heart disease
  • Vasculitis
  • Arterial dissection
  • Sickle cell disease
  • Neurocutaneous syndromes
  • Vascular malformations
  • Meningitis

Treatment

Pre-Hospital

  • Rapid assessment of neurologic deficits
  • Consider transport to a stroke center, when available, if deficits persist

Initial Stabilization/Therapy

  • IV access
  • Cardiac monitoring
  • Supplemental oxygen if hypoxic

Ed Treatment/Procedures

  • Main goals in the management of TIA:Improve perfusion to ischemic tissuePrevent a subsequent stroke
  • BP management:BP should not be lowered acutely unless over 220/120 mm HgHypertensive patients with TIA should have their BP lowered if stable at 24 hr after TIAKey in patients upon discharge1st line " “ HCTZ or ACE inhibitor
  • Antiplatelet therapy:All patients, in the absence of contraindications, need antiplatelet therapy for stroke prevention1st line " “ aspirin (ASA):Safe, cheap, effectiveASA allergy " “ clopidogrel, ticlopidineASA/dipyridamole may be more effective than ASA alone
  • Anticoagulation:Indicated for new onset atrial fibrillation or existing atrial fibrillation not on anticoagulantsOptions include heparin/low-molecular-weight heparin with a transition to warfarin or dabigatranThe decision to anticoagulate is not emergent; discuss with admitting physician
  • Carotid endarterectomy (CEA):CEA within 2 wk after TIA in patients with >70% carotid stenosis reduces stroke risk by 10 " “15%
  • Lipid therapy:AHA guidelines recommend statin therapy for patients with TIA with a goal LDL of under 70 mg/dLKey in patients upon discharge
  • Improve perfusion to ischemic tissue
  • Prevent a subsequent stroke
  • BP should not be lowered acutely unless over 220/120 mm Hg
  • Hypertensive patients with TIA should have their BP lowered if stable at 24 hr after TIA
  • Key in patients upon discharge
  • 1st line " “ HCTZ or ACE inhibitor
  • All patients, in the absence of contraindications, need antiplatelet therapy for stroke prevention
  • 1st line " “ aspirin (ASA):Safe, cheap, effective
  • ASA allergy " “ clopidogrel, ticlopidine
  • ASA/dipyridamole may be more effective than ASA alone
  • Safe, cheap, effective
  • Indicated for new onset atrial fibrillation or existing atrial fibrillation not on anticoagulants
  • Options include heparin/low-molecular-weight heparin with a transition to warfarin or dabigatran
  • The decision to anticoagulate is not emergent; discuss with admitting physician
  • CEA within 2 wk after TIA in patients with >70% carotid stenosis reduces stroke risk by 10 " “15%
  • AHA guidelines recommend statin therapy for patients with TIA with a goal LDL of under 70 mg/dL
  • Key in patients upon discharge

Medication

  • Antiplatelet agents:Aspirin 160 " “325 mg dailyAspirin/dipyridamole 25 mg/200 mg dailyClopidogrel 300 mg initially then 75 mg daily
  • Anticoagulation:Heparin 5,000 " “7,500 U IV bolus, followed by 1,000 U/h infusion OR 80 U/kg IV bolus then 18 U/kg/hWarfarin dose is dependent on age and weight, but goal INR for atrial fibrillation is 2 " “3Dabigatran 150 mg daily (normal renal function)
  • Acute BP management:Labetalol 20 mg IV bolus, followed by 20 " “80 mg IV every 10 min; max. cumulative dose of 300 mgNicardipine 5 mg/h infection, increase by 2.5 mg/h every 5 " “15 min; max. dose of 15 mg/h
  • Aspirin 160 " “325 mg daily
  • Aspirin/dipyridamole 25 mg/200 mg daily
  • Clopidogrel 300 mg initially then 75 mg daily
  • Heparin 5,000 " “7,500 U IV bolus, followed by 1,000 U/h infusion OR 80 U/kg IV bolus then 18 U/kg/h
  • Warfarin dose is dependent on age and weight, but goal INR for atrial fibrillation is 2 " “3
  • Dabigatran 150 mg daily (normal renal function)
  • Labetalol 20 mg IV bolus, followed by 20 " “80 mg IV every 10 min; max. cumulative dose of 300 mg
  • Nicardipine 5 mg/h infection, increase by 2.5 mg/h every 5 " “15 min; max. dose of 15 mg/h

Follow-Up

Disposition

  • There are no clear indications for admission or discharge
  • Patients with TIA have variable short-term risk of stroke
  • Goal of admission is to prevent subsequent stroke in high-risk patients
  • Scoring systems have been developed to predict short-term risk of stroke and therefore can guide disposition
  • Most common = ABCD2 score:Age >60 = 1 pointBP >140/90 = 1 pointClinical features:Unilateral weakness = 2 pointsSpeech difficulty alone = 1 pointDuration:>60 min = 2 points10 " “59 min = 1 point<10 min = 0 pointsDiabetes = 1 point
  • ABCD2 score 0 " “3 = low risk of stroke ( ¢ ˆ ¼1% at 7 days)
  • ABCD2 score 4 " “5 = moderate risk for stroke ( ¢ ˆ ¼6% at 7 days)
  • ABCD2 score 6 " “7 = high risk for stroke ( ¢ ˆ ¼12% at 7 days)
  • Patients with moderate to high risk for short-term stroke = admission
  • Patients with low risk for short-term stroke, but poor follow-up = observation unit
  • Age >60 = 1 point
  • BP >140/90 = 1 point
  • Clinical features:Unilateral weakness = 2 pointsSpeech difficulty alone = 1 point
  • Duration:>60 min = 2 points10 " “59 min = 1 point<10 min = 0 points
  • Diabetes = 1 point
  • Unilateral weakness = 2 points
  • Speech difficulty alone = 1 point
  • >60 min = 2 points
  • 10 " “59 min = 1 point
  • <10 min = 0 points
  • No clear discharge criteria exist:Low risk for short-term stroke, with good follow-up
  • Low risk for short-term stroke, with good follow-up
  • The risk of stroke after TIA is highest within 2 days of symptoms
  • Discharged patients need to see neurology/primary care within 24 " “48 hr

Follow-Up Recommendations

  • Primary Care/Neurology " “ management of risk factors for cerebrovascular disease (hypertension, diabetes, etc.)
  • Vascular surgery " “ for carotid stenosis. Follow-up within 1 wk, plan for possible CEA within 2 wk
  • Cardiology " “ for those patients with cardiac cause of stroke, such as atrial fibrillation or cardiomyopathy

Pearls and Pitfalls

  • Pearls:Risk stratification scores (such as ABCD2) can help guide dispositionPatients with carotid stenosis need rapid vascular surgery follow-up
  • Pitfalls:Failure to recognize the subtle lacunar TIA syndromes, such as sensory lossFailure to rapidly check a glucose in a patient with a focal neurologic deficitDischarging patients with TIA without close outpatient follow-up
  • Risk stratification scores (such as ABCD2) can help guide disposition
  • Patients with carotid stenosis need rapid vascular surgery follow-up
  • Failure to recognize the subtle lacunar TIA syndromes, such as sensory loss
  • Failure to rapidly check a glucose in a patient with a focal neurologic deficit
  • Discharging patients with TIA without close outpatient follow-up

Additional Reading

  • Davis ‚ SM, Donnan ‚ GA. Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack. New Engl J Med. 2012;366:1914 " “1922.
  • Panagos ‚ PD. Transient ischemic attack (TIA): The initial diagnostic and therapeutic dilemma. Am J Emerg Med. 2012;30:794 " “799.
  • Pare ‚ JR, Kahn ‚ JH. Basic neuroanatomy and stroke syndromes. Emerg Med Clin North Am. 2012;30:601 " “615.
  • Siket ‚ MS, Edlow ‚ JA. Transient ischemic attack: Reviewing the evolution of the definition, diagnosis, risk stratification, and management for the emergency physician. Emerg Med Clin North Am. 2012;30:745 " “770.
  • Sorensen ‚ AG, Ay ‚ H. Transient ischemic attack: Definition, diagnosis, and risk stratification. Neuroimaging Clin N Am. 2011;21:303 " “313.

Codes

ICD9

  • 435.3 Vertebrobasilar artery syndrome
  • 435.8 Other specified transient cerebral ischemias
  • 435.9 Unspecified transient cerebral ischemia

ICD10

  • G45.8 Oth transient cerebral ischemic attacks and related synd
  • G45.9 Transient cerebral ischemic attack, unspecified
  • G46.1 Anterior cerebral artery syndrome
  • G46.0 Middle cerebral artery syndrome
  • G46.2 Posterior cerebral artery syndrome

SNOMED

  • 266257000 Transient ischemic attack (disorder)
  • 195210002 Anterior cerebral artery syndrome (disorder)
  • 195209007 Middle cerebral artery syndrome (disorder)
  • 195211003 Posterior cerebral artery syndrome (disorder)
  • 230716006 Carotid territory transient ischemic attack